(Q44945175)

7 December 2017

title

Statins in rheumatoid arthritis--two birds with one stone? (English)

1 reference

7 December 2017

1

1 reference

7 December 2017

2

Anders Hamsten

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

363

1 reference

7 December 2017

issue

9426

1 reference

7 December 2017

page(s)

2011-2012

1 reference

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

The mortality of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

A novel anti-inflammatory role for simvastatin in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916485-4

7 January 2021

10.1016/S0140-6736(04)16485-4

Identifiers

DOI

1 reference

7 December 2017

1 reference